INDIES reports 13% decline in year end net profits
Crystal Gayle 2019-01-10T21:35:20-05:00Date: January 10, 2018 Indies Pharma Jamaica Limited (INDIES), for the year ended October 31, 2018 reported revenues for the twelve months ended October 31, 2018 of $636.17 million, an increase of 3% when compared with the $620.35 million booked last year. Cost of sales amounted to a total of $243.38 million relative to the